688136.SH
Kexing Biopharm Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 23.60
+14.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 33.85x
- P/E 2027E
- 24.99x
- P/E 2028E
- 18.74x
- P/S forward
- 12.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.64x
- PEG TTM
- —
- Price / book
- 2.59x
- Price / sales
- 2.90x
- Price / cash flow
- 62.81x
Enterprise value
- Enterprise value
- CNY 4.5B
- EV / sales
- 3.08x
- EV / EBITDA
- 16.52x
- EV / EBIT
- 41.52x
- Market cap
- CNY 4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026